TRAVERE THERAPEUTICS, INC. Legal Fees
TRAVERE THERAPEUTICS, INC. (TVTX) reported Legal Fees of $0 for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LegalFees · last filed 2018-11-01
- TRAVERE THERAPEUTICS, INC. legal fees for the quarter ending 2018-09-30 was $0.00.
- TRAVERE THERAPEUTICS, INC. legal fees for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. legal fees for the quarter ending 2017-09-30 was $0.00.
- TRAVERE THERAPEUTICS, INC. legal fees for the quarter ending 2017-06-30 was $2.00M.
- TRAVERE THERAPEUTICS, INC. legal fees for fiscal 2013 was $150.00K, a 73.37% decline from fiscal 2012.
- TRAVERE THERAPEUTICS, INC. legal fees for fiscal 2012 was $563.38K.
| Period end | Legal Fees 3 month | Legal Fees 6 month | Legal Fees 9 month | Legal Fees 12 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 10-Q · filed 2018-11-01 | $0.00 derived: sum of 2 quarters · filed 2018-11-01 | ||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-03 | $0.00 10-Q · filed 2018-08-03 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-01 | $2.00M derived: sum of 2 quarters · filed 2018-11-01 | $2.00M 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $2.00M 10-Q · filed 2018-08-03 | $2.00M 10-Q · filed 2018-08-03 | ||
| 2013-12-31 | $150.00K 10-K/A · filed 2015-07-09 | |||
| 2012-12-31 | $563.38K 10-K · filed 2015-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |